BioSpace News Archive

Here’s a look at five biotech and pharmaceutical innovation trends from 2019.

Chief Executive Officer Scott Shively said the acquisition of an oral analgesic from Johnson & Johnson will be transformative for California-based Neumentum Inc.

Centrient Pharmaceuticals (“Centrient”), the global leader in the production and commercialisation of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has

Great Bay Bio is pleased to announce that a strategic cooperation was reached with Guangzhou Boji Medical Biotechnological Co., Ltd. to jointly develop GBB101, a new long-acting injectable biologics for the treatment of anemia caused by Chronic Kidney Disease A new joint venture company has been created to share the R&D achievements of the project, including intellectual property rights and any rights and interests arising in the R&D process.

Promore Pharma AB held Extraordinary Shareholder’s Meeting on Tuesday, 22 October 2019.

Regenstrief Institute research scientist Theresa Cullen, M.D., has won a Leading for Impact, Women in Leadership award.

Despite booming commercial interest in plant-based and cultivated meat, funding for academic research lags behind and the industries face a dearth of the open-access data that will be required to overcome technical hurdles and scale-up to price parity

MorphoSys AG will publish its first nine months’ 2019 results on October 29, 2019 at 10:00pm CET

Membership into this academy is one of the highest honors in health and medicine

Porton Biopharma Ltd has announced that it has signed a modification to its contract with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases to advance a next generation intra-nasal anthrax vaccine into the clinical-trial phase.